Table 4.
Age at surgery | ≤ 2 Months (n = 23) | > 2 Months (n = 21) | ||||
---|---|---|---|---|---|---|
Liver function | At surgery | 1 week after surgery | P | At surgery | 1 week after surgery | P |
ALT(U/L, M[P25,P75]) | 19.0[13.0,27.0] | 29.0[15.0,43.0] | 0.014 | 45.0[34.0,97.5] | 31.0[23.5,66.0] | 0.035 |
AST(U/L, M[P25,P75]) | 32.0[23.0,41.0] | 32.0[21.0,45.0] | 0.484 | 55.0[37.0,102.0] | 32.0[27.0,62.0] | 0.007 |
γ-GT(U/L, M[P25,P75]) | 229.0[105.0,542.0] | 222.0[120.0,339.0] | 0.465 | 49.0[28.5,300.0] | 98.0[49.5,224.5] | 0.566 |
DBIL(umol/L, M[P25,P75]) | 13.40[7.55,25.92] | 6.30[4.80,13.53] | 0.001 | 4.31[2.17,8.12] | 2.81[2.40,4.37] | 0.013 |
Cholestasis before surgery(Yes/No, n) | 7/16 | 4/19 | 0.300 | 3/18 | 2/19 | 1.000 |
The Wilcoxon test was used to evaluate the ALT, AST, γ-GT, and DBIL levels between the time of surgery and 1 week after surgery at various ages